Logo image of PRN.CA

PROFOUND MEDICAL CORP (PRN.CA) Stock Fundamental Analysis

TSX:PRN - Toronto Stock Exchange - CA74319B5027 - Common Stock - Currency: CAD

9.91  -0.43 (-4.16%)

Fundamental Rating

3

PRN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 15 industry peers in the Health Care Equipment & Supplies industry. While PRN seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, PRN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year PRN has reported negative net income.
In the past year PRN has reported a negative cash flow from operations.
In the past 5 years PRN always reported negative net income.
PRN had a negative operating cash flow in each of the past 5 years.
PRN.CA Yearly Net Income VS EBIT VS OCF VS FCFPRN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

With a decent Return On Assets value of -74.32%, PRN is doing good in the industry, outperforming 66.67% of the companies in the same industry.
With a decent Return On Equity value of -101.05%, PRN is doing good in the industry, outperforming 73.33% of the companies in the same industry.
Industry RankSector Rank
ROA -74.32%
ROE -101.05%
ROIC N/A
ROA(3y)-48.31%
ROA(5y)-43.25%
ROE(3y)-61.61%
ROE(5y)-62.59%
ROIC(3y)N/A
ROIC(5y)N/A
PRN.CA Yearly ROA, ROE, ROICPRN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

PRN has a better Gross Margin (62.02%) than 93.33% of its industry peers.
PRN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for PRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.57%
GM growth 5Y13.97%
PRN.CA Yearly Profit, Operating, Gross MarginsPRN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

More info and screens

5

2. Health

2.1 Basic Checks

PRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
PRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PRN.CA Yearly Shares OutstandingPRN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
PRN.CA Yearly Total Debt VS Total AssetsPRN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

PRN has an Altman-Z score of 1.78. This is a bad value and indicates that PRN is not financially healthy and even has some risk of bankruptcy.
With an excellent Altman-Z score value of 1.78, PRN belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
A Debt/Equity ratio of 0.12 indicates that PRN is not too dependend on debt financing.
PRN has a better Debt to Equity ratio (0.12) than 73.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 1.78
ROIC/WACCN/A
WACC7.85%
PRN.CA Yearly LT Debt VS Equity VS FCFPRN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M 80M

2.3 Liquidity

PRN has a Current Ratio of 6.12. This indicates that PRN is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PRN (6.12) is better than 93.33% of its industry peers.
A Quick Ratio of 5.16 indicates that PRN has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 5.16, PRN belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.12
Quick Ratio 5.16
PRN.CA Yearly Current Assets VS Current LiabilitesPRN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.04% over the past year.
EPS 1Y (TTM)17.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.38%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%108.06%

3.2 Future

Based on estimates for the next years, PRN will show a very strong growth in Earnings Per Share. The EPS will grow by 29.09% on average per year.
The Revenue is expected to grow by 73.02% on average over the next years. This is a very strong growth
EPS Next Y19.06%
EPS Next 2Y16.87%
EPS Next 3Y31.12%
EPS Next 5Y29.09%
Revenue Next Year151.33%
Revenue Next 2Y122.48%
Revenue Next 3Y101.92%
Revenue Next 5Y73.02%

3.3 Evolution

PRN.CA Yearly Revenue VS EstimatesPRN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
PRN.CA Yearly EPS VS EstimatesPRN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

PRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PRN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PRN.CA Price Earnings VS Forward Price EarningsPRN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRN.CA Per share dataPRN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PRN's earnings are expected to grow with 31.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.87%
EPS Next 3Y31.12%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PRN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PROFOUND MEDICAL CORP

TSX:PRN (3/7/2025, 7:00:00 PM)

9.91

-0.43 (-4.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-06 2025-03-06/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners50.32%
Inst Owner ChangeN/A
Ins Owners7.71%
Ins Owner ChangeN/A
Market Cap297.70M
Analysts83.33
Price Target24.91 (151.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.78%
Min EPS beat(2)-28.63%
Max EPS beat(2)5.06%
EPS beat(4)2
Avg EPS beat(4)-11.83%
Min EPS beat(4)-30.15%
Max EPS beat(4)6.39%
EPS beat(8)5
Avg EPS beat(8)-4.08%
EPS beat(12)8
Avg EPS beat(12)0.04%
EPS beat(16)8
Avg EPS beat(16)-5.75%
Revenue beat(2)0
Avg Revenue beat(2)-5.15%
Min Revenue beat(2)-7.61%
Max Revenue beat(2)-2.68%
Revenue beat(4)1
Avg Revenue beat(4)-10.49%
Min Revenue beat(4)-32.27%
Max Revenue beat(4)0.6%
Revenue beat(8)1
Avg Revenue beat(8)-19.92%
Revenue beat(12)2
Avg Revenue beat(12)-21.31%
Revenue beat(16)4
Avg Revenue beat(16)-19.93%
PT rev (1m)17.92%
PT rev (3m)54.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.99%
EPS NY rev (1m)-1.06%
EPS NY rev (3m)-1.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.78%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 23.11
P/FCF N/A
P/OCF N/A
P/B 6.68
P/tB 6.76
EV/EBITDA N/A
EPS(TTM)-1.61
EYN/A
EPS(NY)-1.3
Fwd EYN/A
FCF(TTM)-1.18
FCFYN/A
OCF(TTM)-1.18
OCFYN/A
SpS0.43
BVpS1.48
TBVpS1.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -74.32%
ROE -101.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.02%
FCFM N/A
ROA(3y)-48.31%
ROA(5y)-43.25%
ROE(3y)-61.61%
ROE(5y)-62.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.57%
GM growth 5Y13.97%
F-Score4
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.12
Quick Ratio 5.16
Altman-Z 1.78
F-Score4
WACC7.85%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.38%
EPS Next Y19.06%
EPS Next 2Y16.87%
EPS Next 3Y31.12%
EPS Next 5Y29.09%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%108.06%
Revenue Next Year151.33%
Revenue Next 2Y122.48%
Revenue Next 3Y101.92%
Revenue Next 5Y73.02%
EBIT growth 1Y-26.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4.75%
EBIT Next 3Y29.67%
EBIT Next 5Y34.12%
FCF growth 1Y-1.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2.45%
OCF growth 3YN/A
OCF growth 5YN/A